デフォルト表紙
市場調査レポート
商品コード
1338938

超崩壊剤市場、シェア、規模、動向、産業分析レポート:製品別;剤形別;治療領域別;地域別;セグメント予測、2023~2032年

Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032

出版日: | 発行: Polaris Market Research | ページ情報: 英文 114 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
超崩壊剤市場、シェア、規模、動向、産業分析レポート:製品別;剤形別;治療領域別;地域別;セグメント予測、2023~2032年
出版日: 2023年06月23日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の超崩壊剤市場規模は2032年までに8億2,954万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

心血管疾患、糖尿病、がんなどの慢性疾患の有病率の上昇により、医薬品に対する需要が増加しています。超崩壊剤はこれらの医薬品の製剤化において重要な役割を果たしており、製薬業界において不可欠な成分となっています。非感染性疾患(NCD)による死亡者数は年間1,790万人と最も多く、次いで心血管疾患(930万人)、慢性呼吸器疾患(410万人)、糖尿病(120万人)(糖尿病がもたらす腎疾患による死亡を含む200万人)となっています。これが、今後数年間の市場成長の原動力となると思われます。

技術の進歩により、より効率的な新しい超崩壊剤の開発が進んでいます。例えば、最近の研究では、錠剤やカプセルを含む様々な医薬製剤にバナナ粉末を過剰崩壊剤として使用することが研究されています。これにより、複数の医薬品の製剤化においてこれらの賦形剤の使用が増加しています。ジェネリック医薬品は手頃な価格で入手しやすいため、需要が高まっています。

製薬業界における超崩壊剤の使用の増加と、新しく革新的なソリューションに対する特許出願件数の増加が、超崩壊剤市場の成長を促進しています。米国国立標準技術研究所(NIST)と国連特許商標庁(USPTO)のデータの組み合わせによると、N-ビニルピロリドン+デンプングリコール酸ナトリウムの特許数は15件で、アミロースの14件がこれに続いています。医薬品メーカーがより効率的で効果的なドラッグデリバリーシステムの開発を目指す中、この動向は今後も続くと予想されます。

超崩壊剤市場レポートハイライト

クロスポビドン分野は、速溶性の剤形に対する需要の増加により成長が見込まれます。

錠剤は製薬業界で最も使用される剤形であり、超崩壊剤は錠剤製剤の重要な成分であることから、錠剤分野が最も高い成長率を示しています。

消化器系疾患は、消化器系疾患の罹患率の増加と患者中心のドラッグデリバリーへの注目の高まりにより、著しい成長率を示すと予測されます。

北米は、慢性疾患の罹患率の大幅な増加や技術の進歩により、最大の売上シェアを占めると予測されます。

APACは、中国やインドのような発展途上国における製薬産業の成長により、今後数年間で大きな成長率を示すと予測されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の超崩壊剤市場に関する洞察

  • 超崩壊剤市場- 治療領域のスナップショット
  • 超崩壊剤市場力学
    • 促進要因と機会
      • 口腔内崩壊錠の普及が進む
      • 成長するジェネリック市場
    • 抑制要因と課題
      • 安全性と品質への懸念
  • PESTEL分析
  • 超崩壊剤市場の治療領域の動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界の超崩壊剤市場、製品別

  • 主な調査結果
  • イントロダクション
  • 加工でんぷん
  • 変性セルロース
  • クロスポビドン
  • イオン交換樹脂

第6章 世界の超崩壊剤市場、剤形別

  • 主な調査結果
  • イントロダクション
  • タブレット
  • カプセル

第7章 世界の超崩壊剤市場、治療領域別

  • 主な調査結果
  • イントロダクション
  • 消化器疾患
  • 神経疾患
  • 腫瘍学
  • 感染症
  • 心血管疾患
  • 血液疾患
  • 炎症性疾患

第8章 世界の超崩壊剤市場、地域別

  • 主な調査結果
  • イントロダクション
    • 超崩壊剤市場評価、地域、2019~2032年
  • 超崩壊剤市場-北米
    • 北米:超崩壊剤市場、製品別、2019~2032年
    • 北米:超崩壊剤市場、治療領域別、2019~2032年
    • 北米:超崩壊剤市場、剤形別、2019~2032年
    • 超崩壊剤市場-米国
    • 超崩壊剤市場- カナダ
  • 超崩壊剤市場- 欧州
    • 欧州:超崩壊剤市場、製品別、2019~2032年
    • 欧州:超崩壊剤市場、治療領域別、2019~2032年
    • 欧州:超崩壊剤市場、剤形別、2019~2032年
    • 超崩壊剤市場- 英国
    • 超崩壊剤市場- フランス
    • 超崩壊剤市場- ドイツ
    • 超崩壊剤市場- イタリア
    • 超崩壊剤市場- スペイン
    • 超崩壊剤市場- オランダ
    • 超崩壊剤市場- ロシア
  • 超崩壊剤市場- アジア太平洋
    • アジア太平洋:超崩壊剤市場、製品別、2019~2032年
    • アジア太平洋:超崩壊剤市場、治療領域別、2019~2032年
    • アジア太平洋:超崩壊剤市場、剤形別、2019~2032年
    • 超崩壊剤市場- 中国
    • 超崩壊剤市場- インド
    • 超崩壊剤市場- マレーシア
    • 超崩壊剤市場- 日本
    • 超崩壊剤市場- インドネシア
    • 超崩壊剤市場- 韓国
  • 超崩壊剤市場-中東およびアフリカ
    • 中東およびアフリカ:超崩壊剤市場、製品別、2019~2032年
    • 中東およびアフリカ:超崩壊剤市場、治療領域別、2019~2032年
    • 中東およびアフリカ:超崩壊剤市場、剤形別、2019~2032年
    • 超崩壊剤市場- サウジアラビア
    • 超崩壊剤市場- アラブ首長国連邦
    • 超崩壊剤市場- イスラエル
    • 超崩壊剤市場- 南アフリカ
  • 超崩壊剤市場-ラテンアメリカ
    • ラテンアメリカ:超崩壊剤市場、製品別、2019~2032年
    • ラテンアメリカ:超崩壊剤市場、治療領域別、2019~2032年
    • ラテンアメリカ:超崩壊剤市場、剤形別、2019~2032年
    • 超崩壊剤市場- メキシコ
    • 超崩壊剤市場- ブラジル
    • 超崩壊剤市場- アルゼンチン

第9章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • BASF
  • Roquette Freres
  • Ashland Global
  • Dow DuPont
  • DFE Pharma
  • Asahi Kasei
  • Merck
  • Corel Pharma & Avantor Performance.
図表

List of Tables

  • Table 1 Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 3 Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 4 Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 7 North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 8 U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 10 U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 11 Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 13 Canada: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 14 Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 16 Europe: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 17 UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 19 UK: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 20 France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 22 France: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 23 Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 25 Germany: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 26 Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 28 Italy: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 29 Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 31 Spain: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 32 Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 34 Netherlands: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 35 Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 37 Russia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 41 China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 43 China: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 44 India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 46 India: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 47 Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 49 Malaysia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 50 Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 52 Japan: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 53 Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 55 Indonesia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 56 South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 58 South Korea: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 65 UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 67 UAE: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 68 Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 70 Israel: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 71 South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 73 South Africa: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 74 Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 76 Latin America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 77 Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 79 Mexico: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 80 Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 82 Brazil: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • Table 83 Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • Table 85 Argentina: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Superdisintegrants Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Formulation
  • Figure 7. Global Superdisintegrants Market, by Formulation, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Superdisintegrants Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global Superdisintegrants Market, by Therapeutic Area, 2022 & 2032 (USD Million)
  • Figure 12. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Superdisintegrants Market
目次
Product Code: PM3382

The global superdisintegrants market size is expected to reach USD 829.54 million by 2032, according to a new study by Polaris Market Research. The report "Superdisintegrants Market Share, Size, Trends, Industry Analysis Report, By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin); By Formulation; By Therapeutic Area; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, and cancer has increased the demand for drugs. Superdisintegrants play a vital role in formulating these drugs, making them essential components in the pharmaceutical industry. The most non-communicable disease deaths (NCD), 17.9 million per year, are caused by cardiovascular diseases, followed by cancer (9.3 million), chronic respiratory conditions (4.1 million), and diabetes (1.2 million) (2.0 million, including fatalities from renal disease brought on by diabetes)). This will drive the growth of the market in the upcoming years.

Advancements in technology have led to the development of new and more efficient super disintegrants. For instance, recent studies have investigated using banana powder as a super disintegrant in various pharmaceutical formulations, including tablets and capsules. This has led to increased use of these excipients in formulating multiple drugs. The demand for generic drugs is rising due to their affordability and accessibility.

The increasing use of super disintegrants in the pharmaceutical industry, coupled with the growing number of patents being filed for new and innovative solutions, is driving the growth of the super disintegrants market. According to the combination of data from the National Institute of Standards & Technology (NIST) and the United Nations Patent and Trademark Office (USPTO), N-Vinyl pyrrolidone+sodium starch glycolate has 15 patents, followed by Amylose with 14 patents. This trend is expected to continue in the coming years as drug manufacturers seek to develop more efficient and effective drug delivery systems.

Superdisintegrants Market Report Highlights

Crospovidone segment is anticipated to grow due to increasing demand for fast dissolving dosage forms.

Tablets segment is registered the highest growth rate owing to the as tablets are the most used dosage form in the pharmaceutical industry and superdisintegrants are critical ingredients in tablet formulations.

Gastrointestinal diseases are projected to experience significant growth rate due to the growing incidence of GI disorders and increased focus on patient-centric drug delivery.

North America is expected to have the largest revenue share owing to the strong increasing incidence of chronic diseases and technological advancements.

APAC is projected to witness significant growth rate in the coming years due to the growing pharmaceutical industry in developing countries like China and India.

The global players include: BASF, Ashland Global, Dow DuPont, Roquette Freres, DFE Pharma, JRS PHARMA, Asahi Kasei, Merck, Corel Pharma & Avantor Performance.

Polaris Market Research has segmented the superdisintegrants market report based on product, formulation, therapeutic area, and region:

Superdisintegrants, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • Modified Starch
  • Modified Cellulose
  • Crospovidone
  • Ion Exchange Resin

Superdisintegrants, Formulation Outlook (Revenue - USD Million, 2019 - 2032)

  • Tablets
  • Capsules

Superdisintegrants, Therapeutic area Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastrointestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Superdisintegrants, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Superdisintegrants Market Insights

  • 4.1. Superdisintegrants Market - Therapeutic Area Snapshot
  • 4.2. Superdisintegrants Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Adoption of Orally Disintegrating Tablets
      • 4.2.1.2. Growing Generics Market
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Safety and Quality Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Superdisintegrants Market Therapeutic Area Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Superdisintegrants Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Superdisintegrants Market, by Product, 2019-2032 (USD Million)
  • 5.3. Modified Starch
    • 5.3.1. Global Superdisintegrants Market, by Modified Starch, by Region, 2019-2032 (USD Million)
  • 5.4. Modified Cellulose
    • 5.4.1. Global Superdisintegrants Market, by Modified Cellulose, by Region, 2019-2032 (USD Million)
  • 5.5. Crospovidone
    • 5.5.1. Global Superdisintegrants Market, by Crospovidone, by Region, 2019-2032 (USD Million)
  • 5.6. Ion Exchange Resin
    • 5.6.1. Global Superdisintegrants Market, by Ion Exchange Resin, by Region, 2019-2032 (USD Million)

6. Global Superdisintegrants Market, by Formulation

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 6.3. Tablets
    • 6.3.1. Global Superdisintegrants Market, by Tablets by Region, 2019-2032 (USD Million)
  • 6.4. Capsules
    • 6.4.1. Global Superdisintegrants Market, by Capsules, by Region, 2019-2032 (USD Million)

7. Global Superdisintegrants Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
  • 7.3. Gastrointestinal Diseases
    • 7.3.1. Global Superdisintegrants Market, by Gastrointestinal Diseases, By Region, 2019-2032 (USD Million)
  • 7.4. Neurological Diseases
    • 7.4.1. Global Superdisintegrants Market, by Neurological Diseases, By Region, 2019-2032 (USD Million)
  • 7.5. Oncology
    • 7.5.1. Global Superdisintegrants Market, by Oncology, By Region, 2019-2032 (USD Million)
  • 7.6. Infectious Diseases
    • 7.6.1. Global Superdisintegrants Market, by Infectious Diseases, By Region, 2019-2032 (USD Million)
  • 7.7. Cardiovascular Diseases
    • 7.7.1. Global Superdisintegrants Market, by Cardiovascular Diseases, By Region, 2019-2032 (USD Million)
  • 7.8. Hematological Diseases
    • 7.8.1. Global Superdisintegrants Market, by Hematological Diseases, By Region, 2019-2032 (USD Million)
  • 7.9. Inflammatory Diseases
    • 7.9.1. Global Superdisintegrants Market, by Inflammatory Diseases, By Region, 2019-2032 (USD Million)

8. Global Superdisintegrants Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Superdisintegrants Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Superdisintegrants Market - North America
    • 8.3.1. North America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.3.3. North America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.4. Superdisintegrants Market - U.S.
      • 8.3.4.1. U.S.: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.3.5. Superdisintegrants Market - Canada
      • 8.3.5.1. Canada: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.4. Superdisintegrants Market - Europe
    • 8.4.1. Europe: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.4.3. Europe: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.4. Superdisintegrants Market - UK
      • 8.4.4.1. UK: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.5. Superdisintegrants Market - France
      • 8.4.5.1. France: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.5.3. France: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.6. Superdisintegrants Market - Germany
      • 8.4.6.1. Germany: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.7. Superdisintegrants Market - Italy
      • 8.4.7.1. Italy: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.8. Superdisintegrants Market - Spain
      • 8.4.8.1. Spain: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.9. Superdisintegrants Market - Netherlands
      • 8.4.9.1. Netherlands: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.4.10. Superdisintegrants Market - Russia
      • 8.4.10.1. Russia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.5. Superdisintegrants Market - Asia Pacific
    • 8.5.1. Asia Pacific: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.4. Superdisintegrants Market - China
      • 8.5.4.1. China: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.4.3. China: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.5. Superdisintegrants Market - India
      • 8.5.5.1. India: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.5.3. India: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.6. Superdisintegrants Market - Malaysia
      • 8.5.6.1. Malaysia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.7. Superdisintegrants Market - Japan
      • 8.5.7.1. Japan: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.8. Superdisintegrants Market - Indonesia
      • 8.5.8.1. Indonesia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.5.9. Superdisintegrants Market - South Korea
      • 8.5.9.1. South Korea: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.6. Superdisintegrants Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.4. Superdisintegrants Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.5. Superdisintegrants Market - UAE
      • 8.6.5.1. UAE: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.6. Superdisintegrants Market - Israel
      • 8.6.6.1. Israel: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.6.7. Superdisintegrants Market - South Africa
      • 8.6.7.1. South Africa: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
  • 8.7. Superdisintegrants Market - Latin America
    • 8.7.1. Latin America: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.4. Superdisintegrants Market - Mexico
      • 8.7.4.1. Mexico: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.5. Superdisintegrants Market - Brazil
      • 8.7.5.1. Brazil: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)
    • 8.7.6. Superdisintegrants Market - Argentina
      • 8.7.6.1. Argentina: Superdisintegrants Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Superdisintegrants Market, by Therapeutic Area, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Superdisintegrants Market, by Formulation, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. BASF
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Roquette Freres
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Ashland Global
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Dow DuPont
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. DFE Pharma
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Asahi Kasei
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Corel Pharma & Avantor Performance.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development